Back

Effect of a 12-month treatment with liraglutide, empagliflozin and their combination on carotid intima-media thickness in patients with type 2 diabetes mellitus

30 August 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Aortic, peripheral vascular, and cerebrovascular diseases Carotid Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Dimitrios Vlachomitros

Sismanoglion Hospital, Marousi (Greece)

5 More presentations in this session

Presentation thumbnail
Association between neutrophil count, LDL-C, and long-term carotid plaque progression
Miss M. Li (Suzhou, CN)
Abstract Slides Video
Presentation thumbnail
Stroke subtypes and mortality outcomes in hypertension-related vs. atrial fibrillation-related strokes: a comparative analysis using CDC WONDER
Doctor T. Durrani (Carlisle, GB)
Abstract Slides Video
Presentation thumbnail
A large French family with TGFBR2 pathogenic variant: illustration of variability
Professor G. Jondeau (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Toe brachial indices as predictor of major cardiovascular adverse events
Associate Professor A. Casanegra (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Twelve-month treatment with glucagon-like peptide-1 receptor agonists or sodium-glucose co-transporter-2 inhibitors improves arterial function and myocardial deformation after ischemic stroke
Doctor K. Katogiannis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Aortic, peripheral vascular, and cerebrovascular diseases

The Event

Event poster

ESC Congress 2025

30 August 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on carotid intima-media thickness
thumbnail
Congress Presentation
Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on mitochondrial-derived peptide-c and on markers of neurohumoral activation
thumbnail
Congress Presentation
Twelve-month treatment with glucagon-like peptide-1 receptor agonists or sodium-glucose co-transporter-2 inhibitors improves arterial function and myocardial deformation after ischemic stroke

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources